Clinical trial
Effect of C-Peptide on Diabetic Peripheral Neuropathy
NCT00278980 · Creative Peptides Sweden Inc., Industry · Completed
Key facts
| NCT number | NCT00278980 |
|---|---|
| Title | Effect of C-Peptide on Diabetic Peripheral Neuropathy |
| Official title | Effect of C-Peptide on Diabetic Peripheral Neuropathy, a 6 Months Randomized Double-Blind, Placebo Controlled, Dose-Finding, Multicenter Study, With Parallel Groups |
| Lead sponsor | Creative Peptides Sweden Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 1, Diabetic Polyneuropathy |
| Intervention type | Drug |
| Interventions | C-peptide |
| Enrollment | 180 |
| Start date | Oct 1, 2003 |
| Completion | Dec 1, 2004 |
| First posted | Jan 19, 2006 |
| Last update posted | Jan 19, 2006 |
| Countries | Sweden |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: